Early Diagnosis of Breast Cancer with a Simple Blood Test

On 3 November 2019, at the United Kingdom National Cancer Research Institute (NCRI) Conference, a noteworthy study was presented suggesting that a blood test could be used effectively to diagnose early-stage breast cancer.
The basis of the research idea is that tumor-associated antigens(TAAs) are recognized by immune cells, leading to production of autoantibodies specifically targeting those antigens.
Antigensare special cell-specific structures on the cell surface that enable the cell to be recognized by the immune system . Antibodiesare molecules produced by the immune system’s B lymphocyte cells that bind antigens. Antibodies are also produced in laboratories today, and many new-generation drugs have an antibody structure.

According to the early research findings, these antibodies detectable in blood with a blood test are "proposed" to be detectable approximately 5 years before the clinical manifestations of the disease appear. However, the researchers say it is still too early for full application of this blood test and that further development is required.
Further development is said to potentially make early diagnosis of breast cancer possible through a simple blood test. This study used blood samples from 90 women with breast cancer and 90 healthy women. Using protein microarray technology, the samples were tested for autoantibodies against tumor-associated antigens. Testing showed that a panel containing 9 TAAs provided more reliable results. The panel containing 9 TAAs identified 37% of samples from affected women as diseased and 79% of samples from healthy women as healthy. These results indicate that considerable further work is needed before this blood test can replace highly reliable diagnostic methods such as mammography.
The researchers say developing such a blood test would be less expensive than commonly used techniques. This blood test method for detecting breast cancer is also being developed for early diagnosis of pancreatic, colorectal (large bowel) and liver cancers.
Sources
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.